Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

AZD-6280

Catalog No. T7136Cas No. 942436-93-3

AZD6280 is a novel, subtype-selective GABAAα2/3 receptor positive modulators, used for treatment of generalized anxiety disorder.

AZD-6280

AZD-6280

Purity: 98.99%
Catalog No. T7136Cas No. 942436-93-3
AZD6280 is a novel, subtype-selective GABAAα2/3 receptor positive modulators, used for treatment of generalized anxiety disorder.
Pack SizePriceAvailabilityQuantity
1 mg$239In Stock
5 mg$488In Stock
10 mg$712In Stock
25 mg$1,130In Stock
50 mg$1,580In Stock
100 mg$2,150In Stock
1 mL x 10 mM (in DMSO)$537In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "AZD-6280"

Select Batch
Purity:98.99%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
AZD6280 is a novel, subtype-selective GABAAα2/3 receptor positive modulators, used for treatment of generalized anxiety disorder.
In vivo
The [11C]flumazenil binding was reduced in a dose-dependent, saturable manner by AZD6280. Maximum receptor occupancy could be reached for AZD6280 without causing sedation or cognitive impairment. The K i,plasma estimates for AZD6280 was 440 nmol/l[1].
Animal Research
Two PET studies, using high-resolution research tomography (HRRT) and the radioligand [11C]flumazenil, were performed in 12 subjects at baseline and after administration of single oral doses of AZD7325 (0.2 to 30 mg) and AZD6280 (5 to 40 mg). PET images were analyzed using a simplified reference tissue model, and regional binding potentials (BPND) were obtained. The relationship between plasma concentration of AZD7325 or AZD6280 and GABAA receptor occupancy was described by hyperbolic function, and K i,plasma (plasma concentration required for 50% receptor occupancy) was estimated. Assessments of safety and tolerability included recording of adverse events, vital signs, electrocardiogram, and laboratory tests[1].
Chemical Properties
Molecular Weight366.41
FormulaC20H22N4O3
Cas No.942436-93-3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 25 mg/mL (68.23 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7292 mL13.6459 mL27.2918 mL136.4592 mL
5 mM0.5458 mL2.7292 mL5.4584 mL27.2918 mL
10 mM0.2729 mL1.3646 mL2.7292 mL13.6459 mL
20 mM0.1365 mL0.6823 mL1.3646 mL6.8230 mL
50 mM0.0546 mL0.2729 mL0.5458 mL2.7292 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy AZD-6280 | purchase AZD-6280 | AZD-6280 cost | order AZD-6280 | AZD-6280 chemical structure | AZD-6280 in vivo | AZD-6280 formula | AZD-6280 molecular weight